Clinical Trials Browser

Phase 2 × OTHER × xinmailong × Clear all

NCT03785704 2020-01-22

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Cardiovascular Diseases